DHFR 19-bp deletion and SHMT C1420T polymorphisms and metabolite concentrations of the folate pathway in individuals with down syndrome

Genetic Testing and Molecular Biomarkers

Volumn 17, Issue 4, 2013, Pages 274-277

  Mendes, Cristiani Cortez ^a   Raimundo, Aline Maria Zanchetta De Aquino ^a   Oliveira, Luciana Dutra ^a   Zampieri, Bruna Lancia ^a   Marucci, Gustavo Henrique ^a   Biselli, Joice Matos ^a   Goloni Bertollo, Eny Maria ^a   Eberlin, Marcos Nogueira ^b   Haddad, Renato ^b   Riccio, Maria Francesca ^b   Vannucchi, Hélio ^c   Carvalho, Valdemir Melechco ^d   Pavarino, Érika Cristina ^a  

^a FACULDADE DE MEDICINA DE SÃO JOSÉ DO RIO PRETO   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d Fleury   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROFOLATE REDUCTASE; FOLIC ACID; GLYCINE HYDROXYMETHYLTRANSFERASE; HOMOCYSTEINE; METHYLMALONIC ACID;

ADULT; ARTICLE; CHEMOLUMINESCENCE; CHILD; CONCENTRATION (PARAMETERS); DOWN SYNDROME; FEMALE; FOLIC ACID BLOOD LEVEL; GENE DELETION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INFANT; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; REAL TIME POLYMERASE CHAIN REACTION; SCHOOL CHILD; TANDEM MASS SPECTROMETRY;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DOWN SYNDROME; FEMALE; FOLIC ACID; GENE DELETION; GENE FREQUENCY; GENOTYPE; GLYCINE HYDROXYMETHYLTRANSFERASE; HOMOCYSTEINE; HUMANS; INFANT; MALE; METHYLMALONIC ACID; POLYMORPHISM, GENETIC; TETRAHYDROFOLATE DEHYDROGENASE; YOUNG ADULT;

EID: 84875666463     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2012.0293     Document Type: Article

References (28)

1. Biselli JM, Goloni-Bertollo EM, Haddad R, et al. (2008) The MTR A2756G polymorphism is associated with an increase of plasma homocysteine concentration in Brazilian individuals with Down syndrome. Braz J Med Biol Res 41:34-40.
2. Biselli JM, Zampieri BL, Goloni-Bertollo EM, et al. (2012) Genetic polymorphisms modulate the folate metabolism of Brazilian individuals with Down syndrome. Mol Biol Rep 39:9277-9284.
3. Carvalho VM, Kok F (2008) Determination of serum methylmalonic acid by alkylative extraction and liquid chromatography coupled to tandem mass spectrometry. Anal Biochem 381:67-73.
4. Chen J, Kyte C, Valcin M, et al. (2004) Polymorphisms in the onecarbon metabolic pathway, plasma folate levels and colorectal cancer in a prospective study. Int J Cancer 110:617-620.
5. Coppus AW, Fekkes D, Verhoeven WMA, et al. (2007) Plasma amino acids and neopterin in healthy persons with Down syndrome. J Neural Transm 114:1041-1045.
6. de Andrade CR, Fukada SY, Olivon VC, et al. (2006) Alpha1Dadrenoceptor- induced relaxation on rat carotid artery is impared during the endothelial dysfunction evoked in the early stages of hyperhomocysteinemia. Eur J Pharmacol 543:83-91.
7. Dulucq S, St-Onge G, Gagné V, et al. (2008) DNA variants in the Dihydrofolate reductase gene and outcome in childhood ALL. Blood 111:3692-3700.
8. Fillon-Emery N, Chango A, Mircher C, et al. (2004) Homocysteine concentrations in adults with trisomy 21: effect of B vitamins and genetic polymorphisms. Am J Clin Nutr 80: 1551-1557.
9. Fowler B (2001) The folate cycle and disease in humans. Kidney Int 59:221-229.
10. Fu TF, Hunt S, Schirch V, et al. (2005) Properties of human and rabbit cytosolic serine hydroxymethyltransferase are changed by single nucleotide polymorphic mutations. Arch Biochem Biophys 442:92-101.
11. Gellekink H, Blom HJ, van der Linden IJ, et al. (2007) Molecular genetic analysis of the human Dihydrofolate reductase gene: relation with plasma total homocysteine, serum and red blood cell folate levels. Eur J Hum Genet 15:103-109.
12. Guéant JL, Anello G, Bosco P, et al. (2005) Homocysteine and related genetic polymorphisms in Down syndrome IQ. J Neurol Neurosurg Psychiatry 76:706-709.
13. Haddad R, Mendes MA, Höehr NF, et al. (2001) Amino acid quantitation in aqueous matrices via trap and release membrane introduction mass spectrometry: homocysteine in human plasma. Analyst 126:1212-1215.
14. Heil SG, Van der Put NMJ, Waas ET, et al. (2001) Is mutated Serine hydroxymethyltransferase (SHMT) involved in the etiology of neural tube defects? Mol Genet Metab 73:164-172.
15. Ishinohe A, Kanaumi T, Takashima S, et al. (2005) Cystathionine b-synthase is enriched in the brains of Down's patients. Biochem Biophys Res Commun 338:1547-1550.
16. Johnson WG, Stenroos ES, Spychala JR, et al. (2004) New 19 bp deletion polymorphism in intron-1 of Dihydrofolate reductase (DHFR): a risk factor for spina bifida acting in mothers during pregnancy? Am J Med Genet 124A:339-345.
17. Kalmbach RD, Choumenkovitch SF, Troen AP, et al. (2008) A 19-base pair deletion polymorphism in Dihydrofolate reductase is associated with increased unmetabolized folic acid in plasma and decreased red blood cell folate. J Nutr 138:2323- 2327.
18. Licastro F, Marocchi A, Penco S, et al. (2006) Does Down syndrome support the homocysteine theory of atherogenesis? Experience in elderly subjects with trisomy 21. Arch Gerontol Geriatr 43:381-387.
19. Lim U, Peng K, Shane B, et al. (2005) Polymorphisms in cytoplasmic Serine hydroxymethyltransferase and Methylenetetrahydrofolate reductase affect the risk of cardiovascular disease in men. J Nutr 135:1989-1994.
20. Marucci GH, Zampieri BL, Biselli JM, et al. (2012) Polymorphism C1420T of Serine hydroxymethyltransferase gene on maternal risk for Down syndrome. Mol Biol Rep 39:2561-2566.
21. Meguid NA, Dardir AA, El-Sayed EM, et al. (2010) Homocysteine and oxidative stress in Egyptian children with Down syndrome. Clinic Biochem 43:963-967.
22. Mendes CC, Biselli JM, Zampieri BL, et al. (2010) 19-base pair deletion polymorphism of the dihydrofolate reductase (DHFR) gene: maternal risk of Down syndrome and folate metabolism. Sao Paulo Med J 128:215-218.
23. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215.
24. Pogribna M, Melnyk S, Pogribny I, et al. (2001) Homocysteine etabolism in children with Down syndrome: in vitro modulation. Am J Hum Genet 69:88-95.
25. Shin JH, Weitzdoerfer R, Fountoulakis M, et al. (2004) Expression of cystathionine b-synthase, pyridoxal kinase, and ES1 protein homolog (mitochondrial precursor) in fetal Down syndrome brain. Neurochem Int 45:73-79.
26. Skibola CF, Forrest MS, Coppedé F, et al. (2004) Polymorphisms and haplotypes in folate-metabolizing genes and risk of non- Hodgkin lymphoma. Blood 104:2155-2162.
27. Stanisiawska-Sachadyn A, Brown KS, Mitchell LE, et al. (2008) An insertion/deletion polymorphism of the Dihydrofolate reductase (DHFR) gene is associated with serum and red blood cell folate concentrations in women. Hum Genet 123: 289-295.
28. Xu X, Gammon MD, Wetmur JG, et al. (2007) A functional 19- base pair deletion polymorphism of dihydrofolate reductase (DHFR) and risk of breast cancer in multivitamin users. Am J Clin Nutr 85:1098-1102.